There is no difference in safety and efficacy with Tirofiban or Eptifibatide for patients undergoing treatment of large vessel occlusion and underlying intracranial atherosclerosis

Autor: Movva, Hari, Rabah, Rani, Tekle, Wondwossen, Georgiadis, Alexandros, Preston, Laurie, Kotta, Hari, Hassan, Ameer E.
Zdroj: In Interdisciplinary Neurosurgery: Advanced Techniques and Case Management March 2021 23
Databáze: ScienceDirect